Conflicts of Interest
Yoshifumi Tamura received the research funding for this study from SBI Pharmaceutical Co., Ltd. Hiroaki Seino received research funds from Novo Nordisk Pharma Ltd., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., and YL Biologics Ltd., and Sanofi K.K. Nobuichi Kuribayashi received lecture fees from Novo Nordisk Pharma Ltd. The other authors declare no conflict of interest.